Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

552 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems.
Herrinton LJ, Curtis JR, Chen L, Liu L, Delzell E, Lewis JD, Solomon DH, Griffin MR, Ouellet-Hellstom R, Beukelman T, Grijalva CG, Haynes K, Kuriya B, Lii J, Mitchel E, Patkar N, Rassen J, Winthrop KL, Nourjah P, Saag KG. Herrinton LJ, et al. Among authors: haynes k. Pharmacoepidemiol Drug Saf. 2011 Nov;20(11):1199-209. doi: 10.1002/pds.2196. Epub 2011 Sep 15. Pharmacoepidemiol Drug Saf. 2011. PMID: 21919113 Free PMC article.
Cancer incidence in The Health Improvement Network.
Haynes K, Forde KA, Schinnar R, Wong P, Strom BL, Lewis JD. Haynes K, et al. Pharmacoepidemiol Drug Saf. 2009 Aug;18(8):730-6. doi: 10.1002/pds.1774. Pharmacoepidemiol Drug Saf. 2009. PMID: 19479713
Rates of malignancy associated with juvenile idiopathic arthritis and its treatment.
Beukelman T, Haynes K, Curtis JR, Xie F, Chen L, Bemrich-Stolz CJ, Delzell E, Saag KG, Solomon DH, Lewis JD; Safety Assessment of Biological Therapeutics Collaboration. Beukelman T, et al. Among authors: haynes k. Arthritis Rheum. 2012 Apr;64(4):1263-71. doi: 10.1002/art.34348. Epub 2012 Feb 10. Arthritis Rheum. 2012. PMID: 22328538 Free PMC article.
Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies.
Lo Re V 3rd, Haynes K, Ming EE, Wood Ives J, Horne LN, Fortier K, Carbonari DM, Hennessy S, Cardillo S, Reese PP, Reddy KR, Margolis D, Apter A, Kimmel SE, Roy J, Freeman CP, Razzaghi H, Holick CN, Esposito DB, Van Staa TP, Bhullar H, Strom BL. Lo Re V 3rd, et al. Among authors: haynes k. Pharmacoepidemiol Drug Saf. 2012 Nov;21(11):1202-15. doi: 10.1002/pds.3318. Epub 2012 Jul 5. Pharmacoepidemiol Drug Saf. 2012. PMID: 22763953
552 results